New Diabetes Drugs May Bring On Ketoacidosis

Researchers say people with diabetes who took SGLT2 inhibitors were twice as likely to develop the rare condition as those who didn’t take the drug.

Copyright Disclaimer:This article has been RSS syndicated and was originally published here.